JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berger, F. M.
Right arrow Articles by Schwartz, R. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Berger, F. M.
Right arrow Articles by Schwartz, R. P.
Journal of Pharmacology And Experimental Therapeutics, Vol. 93, Issue 3, 362-367, 1948
Copyright © 1948 by American Society for Pharmacology and Experimental Therapeutics


THE TOXICITY AND MUSCULAR EFFECT OF d-TUBOCURARINE COMBINED WITH beta-ERYTHROIDINE, MYANESIN OR EVIPAL

F. M. Berger M. D.1 and R. P. Schwartz M. D.1

1 The Department of Pediatrics and The Department of Surgery, Division of Orthopedics, The University of Rochester School of Medicine and Dentistry, Rochester 7, New York

d-Tubocurarine and beta-erythroidine administered jointly show potentiation in effective and lethal doses. The margin of safety of the mixture of the drugs is smaller than that of d-tubocurarine administered alone. The combined administration of d-tubocurarine and myanesin showed slight potentiation in lethal doses and incomplete additive action in effective doses. d-Tubocurarine and evipal showed incomplete additive action in both effective and lethal doses. The significance of the findings is discussed.

Submitted on March 31, 1948







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1948 by the American Society for Pharmacology and Experimental Therapeutics.